Chris Mitchell

3.3k total citations · 1 hit paper
46 papers, 2.0k citations indexed

About

Chris Mitchell is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Chris Mitchell has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Public Health, Environmental and Occupational Health, 23 papers in Pediatrics, Perinatology and Child Health and 13 papers in Hematology. Recurrent topics in Chris Mitchell's work include Acute Lymphoblastic Leukemia research (31 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Lymphoma Diagnosis and Treatment (9 papers). Chris Mitchell is often cited by papers focused on Acute Lymphoblastic Leukemia research (31 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Lymphoma Diagnosis and Treatment (9 papers). Chris Mitchell collaborates with scholars based in United Kingdom, United States and Australia. Chris Mitchell's co-authors include Ajay Vora, Nick Goulden, Sue Richards, Rachel Wade, Anthony V. Moorman, Clare Rowntree, Rachael Hough, Jeremy Hancock, Sally E. Kinsey and Christine J. Harrison and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Chris Mitchell

46 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

2013 313 citations Ajay Vora, Nick Goulden et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Mitchell United Kingdom	20	1.3k	945	866	466	278	46	2.0k
J T Sandlund United States	20	1.6k 1.2×	872 0.9×	1.1k 1.3×	459 1.0×	446 1.6×	31	2.4k
Sandra Luna‐Fineman United States	21	559 0.4×	545 0.6×	521 0.6×	393 0.8×	438 1.6×	44	2.0k
H. Riehm Germany	22	1.4k 1.0×	703 0.7×	1.0k 1.2×	340 0.7×	413 1.5×	69	2.1k
Osborn B. Eden United Kingdom	15	767 0.6×	418 0.4×	416 0.5×	554 1.2×	374 1.3×	26	1.6k
F Deméocq France	22	424 0.3×	382 0.4×	564 0.7×	204 0.4×	312 1.1×	78	1.5k
H N Sather United States	17	900 0.7×	485 0.5×	470 0.5×	173 0.4×	180 0.6×	22	1.2k
W. Anthony Smithson United States	15	544 0.4×	644 0.7×	148 0.2×	164 0.4×	296 1.1×	19	1.3k
Eva van den Berg Netherlands	28	485 0.4×	282 0.3×	846 1.0×	711 1.5×	648 2.3×	88	2.6k
G. Schellong Germany	25	1.2k 0.9×	617 0.7×	825 1.0×	318 0.7×	595 2.1×	106	2.6k
RD Gelber United States	14	487 0.4×	296 0.3×	355 0.4×	144 0.3×	485 1.7×	35	1.6k

Countries citing papers authored by Chris Mitchell

Since Specialization

Citations

This map shows the geographic impact of Chris Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Mitchell more than expected).

Fields of papers citing papers by Chris Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Mitchell. The network helps show where Chris Mitchell may publish in the future.

Co-authorship network of co-authors of Chris Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Mitchell. A scholar is included among the top collaborators of Chris Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Mitchell. Chris Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mitchell, Chris, et al.. (2019). Cement Pedestal Spacer Technique for Infected Two-stage Revision Knee Arthroplasty: Description and Comparison of Complications. Indian Journal of Orthopaedics. 53(6). 695–699. 4 indexed citations

Sellar, Rob S., Clare Rowntree, Ajay Vora, et al.. (2018). Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003. British Journal of Haematology. 181(4). 515–522. 9 indexed citations

Eiser, Christine, Chris Stride, Ajay Vora, et al.. (2017). Prospective evaluation of quality of life in children treated in UKALL 2003 for acute lymphoblastic leukaemia: A cohort study. Pediatric Blood & Cancer. 64(11). 26 indexed citations

Bartram, Jack, Rachel Wade, Ajay Vora, et al.. (2016). Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997–2003. Archives of Disease in Childhood. 101(5). 449–454. 22 indexed citations

Patrick, Katharine, Rachel Wade, Nicholas Goulden, et al.. (2014). Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial. Blood. 124(21). 3702–3702. 12 indexed citations

Vora, Ajay, Nick Goulden, Chris Mitchell, et al.. (2014). Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. The Lancet Oncology. 15(8). 809–818. 192 indexed citations

Vora, Ajay, Nick Goulden, Rachel Wade, et al.. (2013). Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. The Lancet Oncology. 14(3). 199–209. 313 indexed citations breakdown →

Yassin, Mohamed, et al.. (2013). The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty. International Orthopaedics. 38(5). 1073–1075. 7 indexed citations

Srivastava, Sanjeev Kumar, Chris Mitchell, Aaron Wiegand, et al.. (2012). Ecological implications of standard fire-mapping approaches for fire management of the World Heritage Area, Fraser Island, Australia. International Journal of Wildland Fire. 22(3). 381–393. 18 indexed citations

10.

Rapa, Elizabeth, et al.. (2012). The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread. Clinical & Experimental Metastasis. 29(5). 419–429. 14 indexed citations

11.

Mitchell, Chris & R.J. Harper. (2011). Status and prospects of carbon forestry in Australia. Murdoch Research Repository (Murdoch University). 8 indexed citations

12.

Qureshi, Amrana, Chris Mitchell, Sue Richards, Ajay Vora, & Nick Goulden. (2010). Asparaginase‐related venous thrombosis in UKALL 2003‐ re‐exposure to asparaginase is feasible and safe. British Journal of Haematology. 149(3). 410–413. 50 indexed citations

13.

Mitchell, Chris. (2007). Clinical trials in paediatric haematology-oncology: are future successes threatened by the EU directive on the conduct of clinical trials?. Archives of Disease in Childhood. 92(11). 1024–1027. 11 indexed citations

14.

Vora, Ajay, Chris Mitchell, Lynne Lennard, et al.. (2006). Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. The Lancet. 368(9544). 1339–1348. 132 indexed citations

15.

Roman, Eve, Jill Simpson, Pat Ansell, et al.. (2005). Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. European Journal of Cancer. 41(5). 749–759. 71 indexed citations

16.

Harewood, Louise, Hazel M. Robinson, Rachel L. Harris, et al.. (2003). Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia. 17(3). 547–553. 100 indexed citations

17.

Somervaille, Tim C. P., Ian Hann, G Harrison, et al.. (2003). Intraocular relapse of childhood acute lymphoblastic leukaemia. British Journal of Haematology. 121(2). 280–286. 27 indexed citations

18.

Vora, Ajay, Chris Mitchell, Sally E. Kinsey, et al.. (2002). Thioguanine-Related Veno-Occlusive Disease of the Liver in Children with Acute Lymphoblastic Leukaemia Report from United Kingdom Medical Research Council Trial ALL97. Blood. 100(11). 12616. 2 indexed citations

19.

Vujanić, Gordan, Anna Kelsey, Chris Mitchell, R S Shannon, & P. Gornall. (2002). The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3. Medical and Pediatric Oncology. 40(1). 18–22. 102 indexed citations

20.

Kinsey, Sally E., et al.. (2001). Progressive reduction in treatment related deaths in MRC Childhood Lymphoblastic Leukaemia trials from 1980 to 1997 (UK ALL VIII, X and XI. British Journal of Haematology. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact